Compounded pharmaceutical composition and process to treat an individual suffering from a cognitive impairment or impaired attention or stimulus

摘要

The present invention provides novel compounds having activity as histamine H3-receptor antagonists. The novel compounds include 4-imidazolyl-N-substituted pyrrolidines, piperidines, and cycloheptimides. The preferred compounds are 4-imidazolyl-N-(cycloalkyl/aryl-alkyl-carbonyl) piperidines such as 4-(1-cyclohexylvaleryol-4-piperidyl)-1H-imidazole.